HomeResource CenterPharmacy EducationBuilding Partnerships
EDUCATIONAL ARTICLE

Best Practices for Building Long-Term Pharmacy Partnerships

Strategic guidance for physicians, clinic owners, and healthcare entrepreneurs on building durable, compliant, and operationally effective relationships with compounding pharmacy partners.

The Strategic Value of Strong Pharmacy Partnerships

For medical practices that rely on compounded medications — whether for hormone therapy, weight management, peptide protocols, or specialty formulations — the pharmacy relationship is a strategic asset, not just a vendor arrangement. Strong pharmacy partnerships deliver clinical value through reliable, high-quality formulations; operational value through efficient workflows and consistent supply; and financial value through competitive pricing and partnership programs.

Building these partnerships takes intentional effort. The practices that develop the strongest pharmacy relationships treat them as true partnerships — with clear expectations, regular communication, mutual accountability, and a shared commitment to patient outcomes. This guide outlines the key practices that distinguish high-performing pharmacy partnerships from transactional vendor relationships.

Seven Best Practices for Pharmacy Partnership Success

01

Start with Rigorous Due Diligence

The foundation of a strong pharmacy partnership is thorough due diligence before the relationship begins. Verify licensure, confirm accreditation, review compliance history, request quality documentation, and conduct reference checks with other practices in your specialty. Document your due diligence process and retain records. The time invested upfront pays dividends in reduced risk and better outcomes.

02

Establish Clear Expectations in Writing

Define the terms of your pharmacy partnership in a written agreement that covers formulary access and pricing, turnaround time commitments, quality documentation requirements (COAs, lot numbers), communication protocols for prescription clarifications, recall and quality failure procedures, and compliance responsibilities. A clear written agreement protects both parties and sets the foundation for a professional relationship.

03

Develop a Dedicated Point of Contact

Identify a dedicated account manager or pharmacist at your pharmacy partner who understands your practice's clinical needs and can serve as your primary point of contact. This relationship is invaluable for resolving issues quickly, getting clinical consultation support, and staying informed about formulary changes or regulatory developments that may affect your prescribing.

04

Implement Systematic Quality Monitoring

Don't assume quality — verify it. Request certificates of analysis for each lot of your most commonly prescribed compounds. Track patient outcomes and adverse events. Establish a process for reporting quality concerns to the pharmacy and documenting the pharmacy's response. Regular quality monitoring catches problems early and demonstrates your commitment to patient safety.

05

Stay Current on Regulatory Developments

The regulatory landscape for compounding is dynamic. FDA guidance, drug shortage determinations, state board rule changes, and enforcement actions can all affect your pharmacy partnerships and prescribing practices. Subscribe to relevant regulatory updates, participate in professional association communications, and maintain an open dialogue with your pharmacy partners about regulatory developments that may affect your formulary.

06

Conduct Annual Partnership Reviews

Schedule formal annual reviews of each pharmacy partnership. Assess quality performance (COA results, complaint rates, turnaround times), compliance status (current licensure, accreditation, any new warning letters or enforcement actions), formulary alignment with your evolving clinical needs, and pricing competitiveness. Use these reviews to renegotiate terms, address performance issues, or make decisions about continuing or expanding the relationship.

07

Maintain Backup Pharmacy Relationships

Relying on a single pharmacy partner creates operational risk. Supply disruptions, quality failures, regulatory actions, or business changes at your primary pharmacy can leave your patients without needed medications. Maintain relationships with two to three pharmacy partners so you have backup options if your primary pharmacy cannot fulfill a prescription. This redundancy is particularly important for practices with high prescription volumes or patients who depend on specific compounded formulations.

Partnership Checklist

Licensure verified in all relevant states

Accreditation status confirmed (PCAB/ACHC)

Compliance history reviewed (no active warning letters)

Quality documentation reviewed (COAs, USP compliance)

Written partnership agreement executed

Dedicated account contact identified

Formulary aligned with clinical needs

Pricing and partnership terms negotiated

Shipping and cold-chain protocols confirmed

Quality monitoring process established

Backup pharmacy partners identified

Annual review schedule established

Frequently Asked Questions

How many pharmacy partners should a practice maintain?

Most practices benefit from two to three pharmacy partners — a primary pharmacy for the majority of prescriptions, and one or two specialty or backup pharmacies. This provides redundancy against supply disruptions and allows you to access specialized formularies for specific patient needs.

What should a pharmacy partnership agreement include?

A pharmacy partnership agreement should cover formulary access and pricing, turnaround time commitments, quality documentation requirements, communication protocols, recall and quality failure procedures, compliance responsibilities, exclusivity provisions (if any), and termination terms. Legal review is recommended before executing any partnership agreement.

How do I handle a quality failure from a pharmacy partner?

Document the quality failure thoroughly, notify the pharmacy immediately, request a root cause analysis and corrective action plan, report adverse events to the FDA and state board as required, and evaluate whether to continue the partnership based on the pharmacy's response. Maintain all records related to the quality failure.

Related Resources